|
1
|
Gaine SP and Rubin LJ: Primary pulmonary
hypertension. Lancet. 352:719–725. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Humbert M, Morrell NW, Archer SL, Stenmark
KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O,
Voelkel NF and Rabinovitch M: Cellular and molecular pathobiology
of pulmonary arterial hypertension. J Am Coll Cardiol. 43(12 Suppl
S): 13S–24S. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Owens GK, Kumar MS and Wamhoff BR:
Molecular regulation of vascular smooth muscle cell differentiation
in development and disease. Physiol Rev. 84:767–801. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Orlandi A, Bochaton-Piallat ML, Gabbiani G
and Spagnoli LG: Aging, smooth muscle cells and vascular
pathobiology: Implications for atherosclerosis. Atherosclerosis.
188:221–230. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen B, Calvert AE, Meng X and Nelin LD:
Pharmacologic agents elevating cAMP prevent arginase II expression
and proliferation of pulmonary artery smooth muscle cells. Am J
Respir Cell Mol Biol. 47:218–226. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stenmark KR, Fagan KA and Frid MG:
Hypoxia-induced pulmonary vascular remodeling: Cellular and
molecular mechanisms. Circ Res. 99:675–691. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nicolls MR, Taraseviciene-Stewart L, Rai
PR, Badesch DB and Voelkel NF: Autoimmunity and pulmonary
hypertension: a perspective. Eur Respir J. 26:1110–1118. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sakaguchi S: Naturally arising
Foxp3-expressing CD25+CD4+ regulatory T cells in immunological
tolerance to self and non-self. Nat Immunol. 6:345–352. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng X, Li W, Yang J, Zhang K, Qin W, An
G, Gao F, Wang Y, Zhang C and Zhang Y: Regulatory T cells prevent
plaque disruption in apolipoprotein E-knockout mice. Int J Cardiol.
168:2684–2692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ait-Oufella H, Wang Y, Herbin O, et al:
Natural regulatory T cells limit angiotensin II-induced aneurysm
formation and rupture in mice. Arterioscler Thromb Vasc Biol.
33:2374–2379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mor A, Planer D, Luboshits G, et al: Role
of naturally occurring CD4+CD25+ regulatory T cells in experimental
atherosclerosis. Arterioscler Thromb Vasc Biol. 27:893–900. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yin M, Zhang J, Wang Y, et al: Deficient
CD4+CD25+ T regulatory cell function in patients with abdominal
aortic aneurysms. Arterioscler Thromb Vasc Biol. 30:1825–1831.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guidi L, Felice C, Bonanno G, et al: FOXP3
T regulatory cell modifications in inflammatory bowel disease
patients treated with anti-TNFα agents. Biomed Res Int.
2013:2863682013. View Article : Google Scholar
|
|
14
|
Oka M, Homma N, Taraseviciene-Stewart L,
Morris KG, Kraskauskas D, Burns N, Voelkel NF and McMurtry IF: Rho
kinase-mediated vasoconstriction is important in severe occlusive
pulmonary arterial hypertension in rats. Circ Res. 100:923–929.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu X, Murphy TC, Nanes MS and Hart CM:
PPAR{gamma} regulates hypoxia-induced nox4 expression in human
pulmonary artery smooth muscle cells through NF-{kappa}B. Am J
Physiol Lung Cell Mol Physiol. 299:L559–L566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim JM, Rasmussen JP and Rudensky AY:
Regulatory T cells prevent catastrophic autoimmunity throughout the
lifespan of mice. Nat Immunol. 8:191–197. 2007. View Article : Google Scholar
|
|
17
|
Fang K, Fu W, Beardsley AR, Sun X, Lisanti
MP and Liu J: Overexpression of caveolin-1 inhibits endothelial
cell proliferation by arresting the cell cycle at G0/G1 phase. Cell
Cycle. 6:199–204. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kraaij MD, Savage ND, van der Kooij SW,
Koekkoek K, Wang J, van den Berg JM, Ottenhoff TH, Kuijpers TW,
Holmdahl R, van Kooten C and Gelderman KA: Induction of regulatory
T cells by macrophages is dependent on production of reactive
oxygen species. Proc Natl Acad Sci USA. 107:17686–17691. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hassoun PM, Mouthon L, Barberà JA, et al:
Inflammation, growth factors, and pulmonary vascular remodeling. J
Am Coll Cardiol. 54(1 Suppl): S10–S19. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
El Chami H and Hassoun PM: Inflammatory
mechanisms in the pathogenesis of pulmonary arterial hypertension.
Compr Physiol. 1:1929–1941. 2011.PubMed/NCBI
|
|
21
|
Schober A and Zernecke A: Chemokines in
vascular remodeling. Thromb Haemost. 97:730–737. 2007.PubMed/NCBI
|
|
22
|
Itoh T, Nagaya N, Ishibashi-Ueda H,
Kyotani S, Oya H, Sakamaki F, Kimura H and Nakanishi N: Increased
plasma monocyte chemoattractant protein-1 level in idiopathic
pulmonary arterial hypertension. Respirology. 11:158–163. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Steiner MK, Syrkina OL, Kolliputi N, Mark
EJ, Hales CA and Waxman AB: Interleukin-6 overexpression induces
pulmonary hypertension. Circ Res. 104:236–244. 2009. View Article : Google Scholar
|
|
24
|
Asadullah K, Sterry W and Volk HD:
Interleukin-10 therapy - review of a new approach. Pharmacol Rev.
55:241–69. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ito T, Okada T, Miyashita H, Nomoto T,
Nonaka-Sarukawa M, Uchibori R, Maeda Y, Urabe M, Mizukami H, Kume
A, Takahashi M, Ikeda U, Shimada K and Ozawa K: Interleukin-10
expression mediated by an adeno-associated virus vector prevents
monocrotaline-induced pulmonary arterial hypertension in rats. Circ
Res. 101:734–741. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lavasani S, Dzhambazov B, Nouri M, et al:
A novel probiotic mixture exerts a therapeutic effect on
experimental autoimmune encephalomyelitis mediated by IL-10
producing regulatory T cells. PLoS One. 5:e90092010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Owens GK: Regulation of differentiation of
vascular smooth muscle cells. Physiol Rev. 75:487–517.
1995.PubMed/NCBI
|
|
28
|
Luo Y, Xu DQ, Dong HY, Zhang B, Liu Y, Niu
W, Dong MQ and Li ZC: Tanshinone iia inhibits hypoxia-induced
pulmonary artery smooth muscle cell proliferation via
akt/skp2/p27-associated pathway. PLoS One. 8:e567742013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu L, Quinn DA, Garg HG and Hales C: Gene
expression of cyclin-dependent kinase inhibitors and effect of
heparin on their expression in mice with hypoxia-induced pulmonary
hypertension. Biochem Biophys Res Commun. 345:1565–1572. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dong Y, Sui L, Sugimoto K, Tai Y and
Tokuda M: Cyclin d1-cdk4 complex, a possible critical factor for
cell proliferation and prognosis in laryngeal squamous cell
carcinomas. Int J Cancer. 95:209–215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sakamoto K, Ohki K, Saito M, Nakahara T
and Ishii K: Small molecule cyclin-dependent kinase inhibitors
protect against neuronal cell death in the ischemic-reperfused rat
retina. J Ocul Pharmacol Ther. 27:419–425. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Toyoshima H and Hunter T: P27, a novel
inhibitor of g1 cyclin-cdk protein kinase activity, is related to
p21. Cell. 78:67–74. 1994. View Article : Google Scholar : PubMed/NCBI
|
